Table 2.
Baseline and follow-up adherence and biomarker outcomes (n = 21 of 25).
| Outcome measure | Baseline | 12 weeks | 24 weeks | |||||
| Mean | SD | Mean | SD | P value | Mean | SD | P value | |
| Adherence (VASa) | 74.7 | 16.5 | 93.3 | 6.6 | <.001 | 93.1 | 7.7 | <.001 |
| Prior 4-day adherence (ACTGb) | 2.33 | 1.1 | 3.24 | 0.4 | .002 | 3.19 | 0.9 | .005 |
| Viral load | 2750.2 | 8930.8 | 240.5 | 521.1 | .26 | 28.5 | 47.5 | .23 |
| CD4 cell count | 501.5 | 239.2 | 552.8 | 234.3 | .12 | 544.8 | 228.7 | .37 |
a Visual analog scale.
b AIDS Clinical Trials Group. Response scale: 0 = never, 4 = all the time.